Can You Survive on ONLY the $2,000/Month Emergency CRA Payments?

The Canopy Growth stock continues to underperform in 2020. About 1,000 employees have been laid off after three rounds of cuts. The displaced workers, along with thousands more, badly need the $2,000 monthly emergency CRA payments.

| More on:

Financial dislocation is the universal worry in the 2020 coronavirus outbreak. As businesses grind to a halt, companies are preserving balance sheets while workers are losing jobs. Without regular sources of income, people need temporary relief.

The Canada Emergency Relief Benefit (CERB) is Canada’s emergency measure. It provides $2,000 per month to the employed and self-employed as well as the underemployed. However, can one survive on just this amount being doled out through the Canada Revenue Agency (CRA)?

Taxable benefit

CERB serves as an income replacement benefit while lockdowns are in effect. The federal government is softening the economic blow of the deadly COVID-19 on working Canadians. The $500 per week for up to 16 weeks is meant to tide people over during the health crisis.

Recipients, however, must be aware of the catch. The CERB is taxable and taxpayers need to report this benefit next year when they file income tax returns for the year 2020.

If you receive the maximum CERB benefit of $8,000, the tax rate is 15% or $1,200 at tax time. Thus, the monthly CRA emergency payment is effectively only $6,800. The tax is not deducted upfront. One analyst advises recipients not to spend it all because you will owe the government taxes in 2021.

Displaced workers growing

Before the emergence of the novel coronavirus, the marijuana industry was already struggling. Industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) was incurring massive losses to the detriment of major investor Constellation Brands.

This $8.27 billion cannabis producer is on its third round of employee layoffs. About 1,000 have been given the exit door. The firings were announced via a Zoom group call. The restructuring was the reason given for the layoffs.

The shares of Canopy Growth are among the most volatile in the current environment. WEED posted a 25.4% loss in 2019. As of this writing, the year-to-date loss is 13.4%, with the stock trading at $23.64 per share.

Canopy CEO David Klein has the daunting task of lowering the company’s cost structure while reducing the cash burn at the same time. Apart from the layoffs, there was a multi-million write-down and closures of greenhouses.

In this quarantine era, sales of CBD edibles (+28%) and cannabis-infused beverages (+14%) are rising. Canopy Growth is pursuing the cannabis beverage market that is estimated to be worth US$2.8 billion by 2025.

Still, Canopy Growth is facing profitability challenges. According to a Forbes report, its annual pot sales must be around $3 billion for the company to stay afloat.

Survival mode

The financial sting of the coronavirus is starting to deepen on workers, including the laid-off staff at Canopy Growth. Millions have applied for emergency benefit.

People are in survival mode. It would be difficult to make ends meet with only $2,000, especially with rent and other bills to pay. For those who are renting, the CERB is a minimal supplement.

Overall, the monthly emergency payment will not go far enough. However, the case for a universal basic income is getting stronger, with many Canadians experiencing economic shocks in the present health crisis.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »